[The future of low molecular weight heparins in the curative treatment of deep venous thrombosis].
St-Louis
J
J
Laboratoire d'hémostase, Hôtel-Dieu de Montréal.
St-Louis
J M
JM
D002986:Clinical Trials as Topic; D015951:Factor Xa / Q000187:drug effects; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007408:Intestinal Absorption; D013917:Thrombin / Q000187:drug effects; D013924:Thrombophlebitis / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014463:Ultrasonography
D006495:Heparin, Low-Molecular-Weight; D013917:Thrombin; D015951:Factor Xa
L'avenir des héparines à faible masse moléculaire dans le traitement curatif de la thrombose veineuse profonde.